Cardival Tablet 80 mg

Cardival Tablet is a hypertension and cardiac care medication containing Valsartan 80 mg. Manufactured by Drug International Ltd, this tablet helps manage blood pressure, heart failure, and post-heart attack complications. Priced at ৳10 per unit, it offers affordable therapy with doses tailored to specific conditions.

As an angiotensin II receptor blocker (ARB), Cardival prevents blood vessel narrowing by blocking hormone receptors. It reduces cardiac workload and improves survival rates in heart failure patients. The drug shows minimal interactions with common medications like diuretics or anticoagulants.

Dosage varies: 80-320 mg daily for hypertension, 40-160 mg twice daily for heart failure, and 20-160 mg post-infarction. Avoid abrupt discontinuation. Store below 30°C, away from moisture. Common side effects include dizziness, fatigue, or hyperkalemia. Pregnant women must avoid it due to fetal risks.

Cardival’s strip price is ৳140 (14 tablets), while a 28-tablet pack costs ৳280. Consult doctors before combining with potassium supplements. Ideal for patients seeking cost-effective ARB therapy from a trusted Bangladeshi pharmaceutical brand.

Hypertension: 80-160 mg once daily (max 320 mg). Heart failure: 40-160 mg twice daily. Post-MI: Start 20 mg twice daily, titrate to 160 mg. Adjust dose in renal/hepatic impairment. Take with/without food consistently.

Cardival is generally well tolerated and side effects are rare. The most common side effects include headache, dizziness, fatigue, abdominal pain, cough, diarrhea and nausea. Patient may also experience hyperkalemia, impotency, reduced renal function, allergic reactions, dyspnea, constipation, back pain, muscle cramps, rash, anxiety, insomnia and vertigo. Hypotension may also occur if patient have been taking diuretics along with Cardival.

Pregnancy Category D. Contraindicated in 2nd/3rd trimesters. Breastfeeding: Risk unknown – use alternatives like captopril.

Monitor renal function quarterly. Check potassium levels monthly. Caution in volume-depleted patients. Not removed by hemodialysis.

Pediatric: Not recommended. Geriatric: Start with lower dose. Hepatic impairment: Max 80 mg/day. Renal: Adjust based on eGFR.

Limited data are available related to overdosage in humans. The most likely manifestations of overdosage would be hypotension and tachycardia, bradycardia could occur from parasympathetic (vagal) stimulation. If excessive hypotension occurs, the patient should be placed in the supine position and if necessary, has to be given an intravenous infusion of normal saline.